Literature DB >> 24911400

Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum.

Yong Guo1, Vanda A Lennon2, Bogdan F Gh Popescu3, Carrie Katherine Grouse4, Jordan Topel4, Margherita Milone1, Hans Lassmann5, Joseph E Parisi2, Sean J Pittock2, Dusan Stefoski4, Roumen Balabanov4, Claudia F Lucchinetti1.   

Abstract

IMPORTANCE: Documentation of muscle pathology compatible with targeting of sarcolemmal aquaporin-4 (AQP4) by complement-activating IgG implies involvement of organs beyond the central nervous system in neuromyelitis optica spectrum disorders. OBSERVATIONS: We report on a 51-year-old woman who had relapsing optic neuritis, transverse myelitis, AQP4-IgG seropositivity, and recurrent myalgias with hyperCKemia. A muscle biopsy revealed scattered myofibers with internal nuclei, atrophy, and regeneration but no necrosis. Mild inflammatory exudates, in endomysial and perivascular spaces, consisted of lymphocytes, histiocytes, and scattered eosinophils. The sarcolemma exhibited loss of AQP4 and deposition of IgG and complement activation products, characteristics not seen in control biopsy samples of healthy muscle and immune-mediated myopathies. CONCLUSIONS AND RELEVANCE: Recurrent hyperCKemia accompanying AQP4-IgG seropositivity reflects targeting of skeletal muscle AQP4 by pathogenic IgG. The entity of autoimmune AQP4 myopathy extends the neuromyelitis optica spectrum beyond the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24911400     DOI: 10.1001/jamaneurol.2014.775

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  22 in total

1.  Neuromyelitis optica presenting as intractable vomiting and hyperCKaemia.

Authors:  Tarig Mohammed Abkur; Eílis Foran; Hugh Kearney; Grace Harkin; Valerie Byrnes; John Lynch
Journal:  J Neurol       Date:  2015-11-21       Impact factor: 4.849

Review 2.  Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.

Authors:  Dominique Rosales; Ilya Kister
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806

3.  Hypoxemia, Sleep Disturbances, and Depression Correlated with Fatigue in Neuromyelitis Optica Spectrum Disorder.

Authors:  Jing Pan; Peng Zhao; Hao Cai; Lei Su; Kristofer Wood; Fu-Dong Shi; Ying Fu
Journal:  CNS Neurosci Ther       Date:  2015-06-01       Impact factor: 5.243

Review 4.  Pattern Recognition of the Multiple Sclerosis Syndrome.

Authors:  Rana K Zabad; Renee Stewart; Kathleen M Healey
Journal:  Brain Sci       Date:  2017-10-24

Review 5.  Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.

Authors:  Sean J Pittock; Claudia F Lucchinetti
Journal:  Ann N Y Acad Sci       Date:  2015-06-10       Impact factor: 5.691

Review 6.  Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.

Authors:  Jeffrey L Bennett; Gregory P Owens
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

7.  Affinity-matured 'aquaporumab' anti-aquaporin-4 antibody for therapy of seropositive neuromyelitis optica spectrum disorders.

Authors:  Tianjiao Duan; Lukmanee Tradtrantip; Puay-Wah Phuan; Jeffrey L Bennett; Alan S Verkman
Journal:  Neuropharmacology       Date:  2019-10-22       Impact factor: 5.250

8.  Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.

Authors:  Matthew M Nour; Ichiro Nakashima; Ester Coutinho; Mark Woodhall; Filipa Sousa; Jon Revis; Yoshiki Takai; Jithin George; Joanna Kitley; Maria Ernestina Santos; Joseph M Nour; Fan Cheng; Hiroshi Kuroda; Tatsuro Misu; Ana Martins-da-Silva; Gabriele C DeLuca; Angela Vincent; Jacqueline Palace; Patrick Waters; Kazuo Fujihara; Maria Isabel Leite
Journal:  Neurology       Date:  2015-11-18       Impact factor: 9.910

Review 9.  Aquaporin-4 autoimmunity.

Authors:  Anastasia Zekeridou; Vanda A Lennon
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-05-21

Review 10.  HCV-related central and peripheral nervous system demyelinating disorders.

Authors:  Sara Mariotto; Sergio Ferrari; Salvatore Monaco
Journal:  Inflamm Allergy Drug Targets       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.